Vasomune Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Vasomune Therapeutics's estimated annual revenue is currently $502.5k per year.
- Vasomune Therapeutics's estimated revenue per employee is $100,500
- Vasomune Therapeutics's total funding is $13.5M.
Employee Data
- Vasomune Therapeutics has 5 Employees.
- Vasomune Therapeutics grew their employee count by 0% last year.
Vasomune Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Development | Reveal Email/Phone |
2 | VP Research & Scientific Affairs | Reveal Email/Phone |
3 | Research And Development Scientist | Reveal Email/Phone |
Vasomune Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $18.5M | 92 | -1% | N/A | N/A |
#2 | $14.3M | 71 | 6% | N/A | N/A |
#3 | $36M | 179 | 8% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $17.9M | 93 | 3% | $192.2M | N/A |
#6 | $64.9M | 323 | 4% | N/A | N/A |
#7 | $0.5M | 5 | -55% | N/A | N/A |
#8 | $6.8M | 34 | -41% | N/A | N/A |
#9 | $19.5M | 97 | 23% | N/A | N/A |
#10 | $2.5M | 25 | 19% | N/A | N/A |
What Is Vasomune Therapeutics?
Vasomune Therapeutics is a private biotechnology company developing the next generation of medicine. Our innovative approach focuses on combating vascular dysfunction and defending against illness by modifying the body’s cellular response to disease. Our company’s lead drug candidate targets a signaling molecule responsible for regulating the vascular response to injury (vascular leak) which is associated with a wide range of diseases such as Acute Respiratory Distress Syndrome (ARDS), Acute Kidney Injury, Diabetic Retinopathy and Cardiopulmonary Bypass. Through pioneering the fight against vascular leak and by decreasing the activity of multiple proinflammatory factors, we can greatly increase the chances of patient health and success. For more, visit www.vasomune.com
keywords:N/A
$13.5M
Total Funding
5
Number of Employees
$502.5k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vasomune Therapeutics News
... of novel therapies for the treatment of acute kidney injury. ... Bessor pharma, Kantum Pharma, Nephraegis Therapeutics, Vasomune,...
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 5 | -17% | $15.2M |
#2 | $7.5M | 5 | 0% | N/A |
#3 | $0.1M | 5 | 0% | $0.96M |
#4 | $35M | 5 | 0% | $234.4M |
#5 | $0.4M | 5 | 0% | N/A |